Virus filtration is the technique that removes virus during the process of purification of biopharmaceutical things. The technique uses a polymeric membrane barrier that removes the virus particles and produces more than 98% recovery for proteins that are less not more than 170kDa. The virus filtration feed steams are generally with high product concentrations and high purity. The premature flux is decreased during the said process, which significantly lessens filter capacity. This happens when the small aggregates fouls. These aggregates come from the particles that are already present in the feed stream. This technique is size-based technique and restores virus on surface and within the membrane's pores.
Market Industry Reports (MIR) has published a new report titled "Virus Filtration Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global virus filtration market is estimated to be over US$ 1,200 Mn in 2017. It is anticipated to grow at a CAGR of 12.1% from 2019 to 2030. The continual increasing adoption of biopharmaceuticals, namely biologics and other biotherapeutics has presented a bright prospect for the growth of virus filtration market. Increasing funding for R&D has further led to wide scale adoption of these filtration products for clearance of virus.Major Key Players of the Virus Filtration Market are:
Asahi Kasei, Merck KGaA, Sartorius AG, Thermo Fisher Scientific, General Electric, Charles River, PendoTECH, Danaher, Lonza and Medical Respiratory Devices among others
No comments:
Post a Comment